Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-04-30Clinical Trial Update: A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease [Phase 1, Phase 2]
A pilot study of curcumin and Ginkgo biloba for Alzheimer's disease has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2008-04-24Clinical Trial Update: Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects [Phase 1]
This phase 1 clinical trial update reports on using the radioiodinated imaging agent [123I] AV39 with SPECT to assess protein disposition in…
-
CLINICAL_TRIALS research · 2008-03-05Clinical Trial Update: The Relationship Between Risperdal Treatment and Quality of Life in Patients With Alzheimer's Disease and Behavioural and Psychological Symptoms of Dementia (BPSD) [Phase 4]
Phase 4 clinical trial exploring how risperidone treatment affects quality of life in patients with Alzheimer's disease and behavioral and p…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Effect of Lithium and Divalproex in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial evaluating lithium and divalproex for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment of Alzheimer's Disease With CX516 (Ampalex) [Phase 2]
This document reports the completion of a Phase 2 trial of CX516 (Ampalex) in Alzheimer's disease (dementia).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease [Phase 4]
Phase 4 trial evaluating whether short-term use of statins and NSAIDs alters beta-amyloid levels in Alzheimer’s disease.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Nefiracetam in the Treatment of Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of nefiracetam for Alzheimer's disease has completed. The study was sponsored by the National Institute of Neurologic…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Genetic Studies in Alzheimer's Disease
This report notes the completion of genetic studies in Alzheimer's disease conducted under the NINDS program. It summarizes the key genetic …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: The Effect of Acetylcholine on Memory and Attention
This completed clinical trial studied how acetylcholine affects memory and attention. It included participants with Alzheimer's disease and …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Preliminary Study of Fish Oil and Dementia [NA]
A completed preliminary clinical study from Taipei City Psychiatric Center evaluated fish oil (omega-3 fatty acids) for dementia-related out…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Diagnosis and Natural History Study of Patients With Neurological Conditions
An update on a NINDS-sponsored diagnosis and natural history study of patients with neurological conditions, including Alzheimer's disease, …
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Brain Imaging in Alzheimer's Disease
A completed brain imaging study in Alzheimer disease is reported in this clinical trial update, sponsored by the National Institute of Menta…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: PET Scan of Brain Metabolism in Relation to Age and Disease
Completed clinical trial update describing PET imaging of brain metabolism across age and disease, including Alzheimer's disease, brain neop…
-
CLINICAL_TRIALS research · 2008-03-04Clinical Trial Update: Brain Imaging in Elderly People and Individuals With Alzheimer's Disease
A completed brain imaging study involving elderly participants, including individuals with Alzheimer's disease and healthy controls.
-
CLINICAL_TRIALS research · 2008-03-03Clinical Trial Update: An Innovative Psychosocial Intervention for Adult-Child Caregivers of Parents With Alzheimer's Disease [NA]
This document provides an update on a clinical trial evaluating a psychosocial intervention for adult-child caregivers of parents with Alzhe…
-
CLINICAL_TRIALS trial_result · 2008-02-21Clinical Trial Update: Huperzine A in Alzheimer's Disease [Phase 2]
Phase 2 clinical trial of huperzine A for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-20Clinical Trial Update: TRx0014 in Patients With Mild or Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial update of TRx0014 in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2008-02-18Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315 [Phase 1]
Phase 1 study evaluating SAM-315 for Alzheimer's disease was terminated; the trial assessed safety, tolerability, pharmacokinetics and pharm…
-
CLINICAL_TRIALS trial_result · 2008-02-06Clinical Trial Update: Treatment With Copper in Patients With Mild Alzheimer´s Dementia [Phase 2]
A Phase 2 trial evaluating copper supplementation in patients with mild Alzheimer's disease has completed.
-
CLINICAL_TRIALS research · 2008-02-05Clinical Trial Update: Prevention of Cognitive Decline in Alzheimer's Disease by Ingested Interferon Alpha [Phase 2]
A Phase 2 clinical trial investigates whether ingested interferon-alpha can prevent cognitive decline in individuals with Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2008-02-05Clinical Trial Update: A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI [NA]
Pfizer-sponsored randomized, placebo-controlled trial evaluated donepezil for mild cognitive impairment, with Alzheimer's disease listed as …
-
CLINICAL_TRIALS trial_result · 2008-02-01Clinical Trial Update: Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics Study of Bryostatin 1 in Patients With Alzheimer's Disease [Phase 2]
Phase 2 study evaluating Bryostatin-1 in Alzheimer's disease reports on safety, efficacy, pharmacokinetics, and pharmacodynamics.
-
CLINICAL_TRIALS trial_result · 2008-01-30Clinical Trial Update: Short Term Effects of PRX-03140 in Patients With Mild Alzheimer's Disease Being Treated With Aricept [Phase 2]
Phase 2 study completed to evaluate the short-term effects of PRX-03140 in patients with mild Alzheimer's disease who were also taking Arice…
-
CLINICAL_TRIALS trial_result · 2008-01-16Clinical Trial Update: Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease [Phase 2]
A Phase 2 study assessing the safety, tolerability, and exploratory efficacy of the investigational compound PBT2 in patients with early Alz…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) [Phase 4]
A Phase 4 clinical trial evaluating memantine for cognitive and MRI volumetric measures in moderate Alzheimer's disease has completed.